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Estrogen deficiency 
heterogeneously affects tissue 
specific stem cells in mice
Yuriko Kitajima1,2, Hanako Doi1, Yusuke Ono1, Yoshishige Urata1, Shinji Goto1, 
Michio Kitajima2, Kiyonori Miura2, Tao-Sheng Li1 & Hideaki Masuzaki2
Postmenopausal disorders are frequently observed in various organs, but their relationship with 
estrogen deficiency and mechanisms remain unclear. As tissue-specific stem cells have been found to 
express estrogen receptors, we examined the hypothesis that estrogen deficiency impairs stem cells, 
which consequently contributes to postmenopausal disorders. Six-week-old C57BL/6 female mice 
were ovariectomized, following which they received 17β-estradiol replacement or vehicle (control). 
Sham-operated mice were used as healthy controls. All mice were killed for evaluation 2 months after 
treatments. Compared with the healthy control, ovariectomy significantly decreased uterine weight, 
which was partially recovered by 17β-estradiol replacement. Ovariectomy significantly increased 
the numbers of c-kit-positive hematopoietic stem/progenitor cells in bone marrow, but impaired 
their capacity to grow mixed cell-type colonies in vitro. Estrogen replacement further increased the 
numbers of c-kit-positive hematopoietic stem/progenitor cells in bone marrow, without significantly 
affecting colony growth in vitro. The number of CD105-positive mesenchymal stem cells in bone 
marrow also significantly decreased after ovariectomy, but completely recovered following estrogen 
replacement. Otherwise, neither ovariectomy nor estrogen replacement changed the number 
of Pax7-positive satellite cells, which are a skeletal muscle-type stem cell. Estrogen deficiency 
heterogeneously affected tissue-specific stem cells, suggesting a likely and direct relationship with 
postmenopausal disorders.
The physiological changes caused by urogenital atrophy can induce a number of pathological disorders, 
such as osteoporosis, thromboembolism, arteriosclerosis, and muscle atrophy, all of which are frequently 
observed following menopause1. These pathological disorders are considered to be associated, at least 
partially, with ovarian dysfunction, especially estrogen deficiency2. Therefore, hormone replacement 
therapy (HRT) is popularly accepted to prevent/alleviate these postmenopausal disorders3. HRT has been 
found to be beneficial, but is also accompanied by side effects and may induce some complications of its 
own4. As many other common pathogenic factors are also well known to contribute to these disorders, 
we must confirm their relationship with estrogen deficiency and gain further understanding of the rele-
vant mechanisms at the molecular and cellular levels.
The rapid advancement on stem cell research in past decades has clearly identified stem cells in 
almost all tissues/organs of our body, and these tissue specific stem/progenitor cells are functionally 
known to be critical in the repair/regeneration of tissue/organs due to physiological turnover or patho-
logical damage5,6. Aging and many other pathogenic factors, such as diabetes mellitus, can impair these 
tissue-specific stem cells7. Interestingly, recent studies have found that the resident stem cells in different 
tissues/organs, including hematopoietic stem cells, endothelial progenitors, mesenchymal stem cells, and 
satellite cells (skeletal muscle-type stem cells) express estrogen receptors8–11. It has also been reported 
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that estrogen plays critical roles in regulating the survival and differentiation of either embryonic stem 
cells or tissue-specific stem/progenitor cells12. Considering the potential roles of estrogen in maintaining 
stem cells, it is quite possible that estrogen deficiency causes a decrease in the quantity and quality of 
stem/progenitor cells, which consequently contributes to postmenopausal disorders in various tissues/
organs.
Using an ovariectomy model in young healthy female mice, we herein examined how estrogen defi-
ciency could affect hematopoietic and mesenchymal stem cells in bone marrow, as well as satellite cells 
in muscles.
Results
Estrogen deficiency induced uterine atrophy and increased body weight. The body weight of 
mice was significantly higher in the Ovx and E groups compared with C group (P = 0.0001 and 0.0108, 
Fig. 1A). The uterine weight was significantly lower in the Ovx group compared with E and C groups 
(P = 0.0001, Fig. 1A), although the uterine weight was also significantly lower in the E group compared 
with the C group (P = 0.008, Fig. 1B). These results indicate that partial atrophy of the uterus occurred 
following estrogen replacement during the 2 months after ovariectomy.
Estrogen deficiency increased the number, but impaired the function, of c-kit+ hematopoi-
etic stem/progenitor cells. Although all procedures were performed with well-trained skill and a 
defined protocol, we collected significantly more BM-MNCs in the E group compared with the C and 
Ovx groups (P = 0.0019 and 0.0094, Fig.  2A). The expression of CXCR4 in BM-MNCs did not differ 
between the C and Ovx groups, but was significantly enhanced in the E group (P = 0.002 and 0.009 vs. C 
and Ovx groups, Fig. 2B). The intracellular ROS level in BM-MNCs was not significantly different among 
groups, although it was slightly increased in the E group (Fig. 2C).
Moreover, compared with healthy mice in the C group, the expression of c-kit, a marker popularly 
used for identifying hematopoietic stem/progenitors cells, was detected to be significantly higher in the 
Ovx group (3.27 ± 0.14% vs. 2.65 ± 0.09%, P = 0.0026; Fig. 3). Strangely, the expression of c-kit was even 
further increased by estrogen replacement (4.87 ± 0.16%, P = 0.0001 vs. C and Ovx groups, Fig. 3).
The results of the colony-forming assay, a method well used for evaluating the function of hemato-
poietic stem/progenitor cells in vitro, showed that the total number of colonies formed from 2 × 104 
BM-MNCs was not significantly different among groups (Fig. 4A). Interestingly, the number of colonies 
of mixed cell type, a subtype of colonies that formed from an even earlier stage of stem/progenitor cells, 
tended to decrease in the Ovx group compared with the C group (19.5 ± 4.6 vs. 26.7 ± 3.5, P = 0.09; 
Fig.  4B), but the decrease was completely recovered by estrogen replacement treatment (30.2 ± 5.1, 
P = 0.57 vs. C group; Fig. 4B).
Estrogen deficiency increased the number of CD105+ mesenchymal stem cells in the bone 
marrow. We also measured the expressions of CD90 and CD105, two popular markers used for the 
identifying mesenchymal stem cells. The expression of CD90 in BM-MNCs did not significantly differ 
among groups (Fig. 5A). However, the expression of CD105 in BM-MNCs was significantly lower in the 
Ovx group compared with the C group (1.78 ± 0.25% vs. 2.10 ± 0.16%, P = 0.042; Fig. 5B), and was at 
the highest level in the E group (3.53 ± 0.29%, P = 0.0001 vs. C group; Fig. 5B).
Figure 1. Body weight and uterine weight. Body weight (A) and uterine weight (B) were measured 2 
months after treatments.
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Estrogen deficiency did not change the number of satellite cells in skeletal muscle. By 
counting the number of Pax7+ satellite cells within the tibialis, we found that there was no significant 
difference among groups (Fig. 6).
Discussion
The present study was designed to examine the hypothesis that estrogen deficiency induces a decrease in 
the quantity and quality of tissue-specific stem cells, thereby contributing to postmenopausal secondary 
disorders in different tissues/organs. Using an ovariectomy model in young healthy female mice, we 
found that estrogen deficiency increased the number, but likely impaired the function, of hematopoietic 
stem/progenitor cells. Estrogen deficiency also significantly decreased the number of CD105+ mesenchy-
mal stem cells in bone marrow, but did not change the number of Pax7+ satellite cells in skeletal muscles. 
Our data shows the heterogeneous effects of estrogen deficiency in different types of tissue-specific stem 
cells, suggesting a likely and direct relationship between the estrogen deficiency-induced impairment of 
stem cells and postmenopausal disorders.
Although estrogens are generally known as female reproductive hormones, the functions of estro-
gens in non-reproductive tissues, such as brain, bone, and cardiovascular systems, are well-defined from 
previous studies13–15. The biological activities of estrogens are mediated by two estrogen receptor (ER) 
Figure 2. The expression of CXCR4 and intracellular ROS levesl in bone marrow mononuclear cells 
(BM-MNCs). (A) The bone marrow was collected from the femur and tibia 2 months after treatments, and 
the number of total collected mononuclear cells from each mouse was directly counted. (B) The expression 
of CXCR4 was detected in freshly collected BM-MNCs by flow cytometry. (C) The intracellular ROS level 
was measured as the mean fluorescence intensity in the freshly collected BM-MNCs after 30 min loading 
with 10-μ M CM-H2DCFDA.
Figure 3. The number of hematopoietic stem/progenitor cells. The expression of c-kit, a marker of 
hematopoietic stem/progenitor cells in bone marrow mononuclear cells, was measured by flow cytometry.
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isoforms, namely ERα and ERβ 15. As stem cells in various tissues express ERs, we examined the role 
of estrogen in stem cells in vivo. We used the well-established ovariectomy-induced estrogen deficiency 
model in young healthy female mice, which were subsequently treated with estrogen replacement or 
placebo. Estrogen deficiency was confirmed by the presence of uterine hypotrophy following ovariec-
tomy. Uterine size was significantly increased by subcutaneous insertion with a slow-release pellet of 
17β -estradiol, an easy method popularly used for estrogen replacement. However, compared with healthy 
mice in the control group, the uterine weight was much lower in mice receiving estrogen replacement 
after ovariectomy. Although we did not monitor the levels of estrogen in mice, the small size of the 
uterus might be due to not enough estrogen being released from the slow-release pellet to maintain it at 
physiological levels, especially during the later periods after subcutaneous insertion.
A recent study found that the treatment with 17β -estradiol enhances the cell cycle and increases the 
numbers of LSK (lin-/Sca-1+ /c-kit+ ) hematopoietic stem cells in wild-type healthy mice, but not in 
ERα -knockout mice8. Unexpectedly, our data revealed that bone marrow mononuclear cells from ova-
riectomized mice contained more c-kit+ hematopoietic stem/progenitor cells, but showed an impaired 
capacity of growth for colonies of mixed cell type in vitro. Estrogen replacement treatment increased 
c-kit+ hematopoietic stem/progenitor cells to an even higher level, and also improved the colony form-
ing capacity. Similar to our data, a very recently published study has also observed an increased number 
Figure 4. Colony-forming assay. Bone marrow mononuclear cells were isolated from mice 2 months after 
treatments. Colony formation was observed under microscopy at 7 days after incubation. The number of all 
types of colonies (30 cells, (A)) and mixed cell type colonies (at least two different types of cell in the colony, 
(B)) were counted.
Figure 5. The number of mesenchymal stem cells. The expression of CD90 (A) and CD105 (B), two 
markers for mesenchymal stem cells in bone marrow mononuclear cells, were measured by flow cytometry.
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of hematopoietic stem cells with impaired function in aged mice16. It is quite possible that estrogen 
deficiency may also increase the number, but decrease the quality of hematopoietic stem/progenitor 
cells. However, further study with longer follow-up is required to answer whether estrogen deficiency 
decreases the number of hematopoietic stem cells. It is also highly required to understand the molecular 
mechanism on estrogen deficiency-induced increase of c-kit-positive stem/progenitor cells.
The expression of CD105, one of the most popularly used markers for the identifying mesenchymal 
stem cells, was significantly decreased in BM-MNCs from ovariectomized mice, but increased with estro-
gen replacement. This suggests that estrogen deficiency might inhibit mesenchymal stem cell function, 
as it did not change the expression of CD90, another marker of mesenchymal stem cells. It is possible 
that some mononuclear cells that are not the phenotype of mesenchymal stem cells, such as matured T 
cells, were positive for CD90, also known as Thy-1, which was originally identified on murine thymo-
cytes and is expressed in T cells17. If this is possible, then estrogen deficiency may reduce the number of 
mesenchymal stem cells in bone marrow.
Satellite cells are the myogenic progenitor cells of postnatal skeletal muscles and reside at the periph-
ery of myofibers in a quiescent state18. Controversial results have previously been reported on the role 
of estrogen in regulating satellite cells. It has been found that estrogen increases the number of satellite 
cells after exercise19, and selective activation of ERβ stimulates skeletal muscle growth and regeneration11. 
In contrast, estrogen has also been demonstrated to repress myogenic differentiation of satellite cells20. 
Although these results lack functional analysis, our data revealed that estrogen deficiency did not change 
the number of satellite cells within 2 months of follow-up. Long-term follow-up is needed to confirm 
this finding.
The reason for the heterogeneity of estrogen deficiency effects in different types of stem cells remains 
unclear. Many studies have reported anti-oxidative and anti-inflammatory effects of estrogens, which 
may be attributed to their phenolic hydroxyl group21. However, the phenolic hydroxyl group present at 
the C3 position of the A ring of estrogen can be oxidized, either by accepting an electron or by losing 
a proton22. In addition, estrogens also produce ROS by increasing mitochondrial activity, thus meaning 
that they also act as pro-oxidants. The controversial role of estrogens as pro-oxidants or anti-oxidants is 
largely dependent on cell type and different expression levels of ERs in a particular cell. Our data indicate 
that estrogen deficiency does not significantly change the intracellular ROS level and the expression of 
CXCR4 in BM-MNCs, suggesting a mineral role of estrogens as an anti-oxidant and anti-inflammatory.
It is critical to compare the expression levels of ERs in different cells after treatments. Unfortunately, 
we failed to quantify the expression of ERS by flow cytometry due to the quality problem of antibodies. 
Therefore, we tried to measure the mRNA expression of ERs in c-kit+ hematopoietic stem cells and sat-
ellite cells (Supplementary Figure). Interestingly, the expression of ERβ was higher in c-kit+ hematopoi-
etic stem/progenitor cells than the matured c-kit− mononuclear cells from bone marrow. However, the 
expressions of ERα and ERβ were even lower in the satellite cells compared with differentiated/matured 
muscle fibers. Although we did not measure the changes of ERs in these cells after different treatments, 
the effect of estrogen deficiency in stem cells may depend, at least partially, on the expression levels of 
ERs, which provides reasonable explanation on the heterogeneity of estrogen deficiency-induced changes 
in different types of stem cells.
In summary, the results of this study revealed that estrogen deficiency heterogeneously affects 
tissue-specific stem cells. Further study, including a longer follow-up, is required to ascertain the estrogen 
Figure 6. The number of satellite cells. Satellite cells were detected in tibialis anterior muscles by 
immunostaining with an anti-Pax7 antibody, and the Pax7-positive cells in randomly selected fields was 
counted under fluorescence microscopy.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:12861 | DOi: 10.1038/srep12861
deficiency-induced impair of tissue-specific stem cells. This may finally uncover the relevant molecular 
and cellular mechanisms, and provide novel strategy for the prevention and treatment of postmenopausal 
disorders.
Materials and Methods
Animals. Six-week-old female C57BL/6 mice were used in this study. All animals were purchased 
from Charles River Laboratories, Kanagawa Japan. All experiments were approved by the Institutional 
Animal Care and Use Committee of Nagasaki University (No. 120721004), and experiments were per-
formed in accordance with the institutional and national guidelines.
Ovariectomy and estrogen replacement treatment. Mice were ovariectomized under anesthe-
sia, and then randomly received subcutaneous insertion of a placebo pellet (Ovx group, n = 8), or a 
slow-release 17β -estradiol pellet (0.01 mg/60 days, Innovative Research of America, FL USA) for estrogen 
replacement (E group, n = 7), as previously described23. Sham-operated mice were used as the healthy 
control (C group, n = 8). All mice were killed 2 months after treatments. The body weight and uterine 
weight were measured, and other tissue samplings and assessments were performed as described in the 
following sections.
Collection of mononuclear cells from bone marrow. Bone marrow cells were collected from the 
femur and tibia. Bone marrow mononuclear cells (BM-MNCs) were isolated by density gradient centrif-
ugation24,25, and then counted using a Nucleo Counter cell-counting device (Chemotetec A/S, Denmark).
Flow cytometry. To measure the number of c-kit-positive (c-kit+) stem/progenitor cells in the freshly 
isolated BM-MNCs, we labeled cells with a PE-conjugated anti-mouse c-kit antibody (eBioscience, CA 
USA) for 30 min. Respective isotype controls were used as a negative control. After washing, quantitative 
flow cytometry analysis was performed using a FACSCalibur instrument (Becton Dickinson, USA)24,25. 
The acquired data was analyzed using Cell Quest software (Becton Dickinson).
BM-MNCs were also stained with goat and rat monoclonal antibodies against CD90 (Abcam, UK), 
CD105 (Abcam), CXCR4 (R&D Systems, USA), followed by their respective FITC-conjugated secondary 
antibodies. The expressions of CD90, CD105, and CXCR4 in BM-MNCs were analyzed by flow cytom-
etry as described above.
Detection of intracellular levels of reactive oxygen species (ROS). To measure the intracellular 
levels of ROS, freshly isolated BM-MNCs were incubated with 10 μ M CM-H2DCFDA (Molecular Probes 
Inc., OR USA), at 37 °C for 30 min26. After washing, the fluorescence intensity in cells was measured by 
flow cytometry as described above.
Colony-forming assay. The colony-forming capacity of the isolated BM-MNCs was estimated using 
mouse methylcellulose complete medium27, according to the manufacturer’s instructions (R&D System, 
MN USA). Briefly, 2 × 104 cells were mixed well with 1 ml of medium, plated in 3-cm culture dishes, and 
incubated at 37 °C in a 5% CO2 incubator. The formation of colonies was observed under a microscope, 
and the total number of colonies in each dish was counted after 7 days of incubation. We also counted 
the number of colonies of mixed cell type, in which at least two different types of cell were growing from 
a single stem/progenitor cell. The mean number of colonies in duplicate assays was used for statistical 
analysis.
Immunohistological staining. To detect the presence of satellite cells, tibialis anterior muscles were 
dissected, frozen in liquid nitrogen, and stored in a − 80 °C refrigerator. Muscle tissues were sectioned 
into 5-μ m-thick sections and fixed with 4% paraformaldehyde for 10 min. After blocking with DAKO 
Protein Block (DAKO, Denmark), sections were incubated with anti-laminin α 2 antibody (Alexis, CA, 
USA) to stain the basal membrane of muscle fibers. Satellite cells that localized to the inside of the 
skeletal basal membrane of muscle fibers were stained using an anti-Pax7 antibody (Santa Cruz, CA, 
USA). All immunostained samples were visualized using their respective secondary antibodies conju-
gated with Alexa Fluor 488 or 568 (Life Technologies, Tokyo, Japan). The nuclei were labeled with DAPI. 
We counted the number of Pax7-positive satellite cells directly under a fluorescence microscope with 
200-fold magnification. We randomly selected at least 10 fields from three sections of each animal, and 
the average cell count per field was used for statistical analysis.
Statistical analyses. All results are presented as the means ± standard error mean (SEM). The sta-
tistical significance was determined by one-way analysis of variance followed by the Bonferroni post hoc 
test (Dr. SPSS II, Chicago, IL). Differences were considered significant when P < 0.05.
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